DMAC icon

DiaMedica Therapeutics
DMAC

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$25
213% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Cantor Fitzgerald
Cantor Fitzgerald
Josh Schimmer
100% 1-yr DMAC win rate
14 Nov ‘25 19 days ago